Skip to content
Transpact Enterprises logo

Transpact Enterprises

542765 BSE
₹100.70

Close ·

View as Markdown
MCP
Close 30 Oct 2026 ₹100.70 −101.75 −50.3% 1Y
Start ₹202.45

Key Fundamentals

MicrocapHealthcare Equipment & SuppliesHealthcare

Price-based figures at the close · TTM

ROCE
13.90%
Debt to Equity
0.11
EPS (TTM)
—
Book Value
₹13.75
Market Cap
—
P/E (TTM)
—
P/B
7.32
ROE
16.20%
Dividend Yield
0.00%
EBITDA
₹10.00 L
52W High
₹234.90
52W Low
₹81.47

Key Insights

Strengths

1
  • Company has reduced debt.

Weaknesses

6
  • Stock is trading at 6.76 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 16.2%
  • Company has a low return on equity of 0.00% over last 3 years.
  • Company has high debtors of 203 days.
  • Promoter holding has decreased over last 3 years: -16.0%

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBearish946
OscillatorsBullish243
Moving AveragesStrong Bearish703

Key readings

RSI (14)
40.22
Neutral
MACD (12,26,9)
−12.09
Bullish
SMA (50)
147.92
Bearish
SMA (200)
186.63
Bearish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
10YZero base
5Y+43.10%
3Y−22.05%
1Y+125.00%

Net profit

Net profit growth by window
10YTurned to profit
5YTurned to profit
3YTurned to profit
1Y+700.00%

Operating cash flow

Operating cash flow growth by window
10YTurned positive
5Y+37.97%
3YTurned positive
1YTurned positive

Operating margin· change in pp

Operating margin growth by window
10YNo sales
5Y+233.34 pp
3Y+74.56 pp
1Y+16.67 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹0.00 Cr
Mar 2018₹0.00 Cr
Mar 2019₹0.13 Cr
Mar 2020₹0.00 Cr
Mar 2021₹0.03 Cr
Mar 2022₹0.15 Cr
Mar 2023₹0.38 Cr
Mar 2024₹0.00 Cr
Mar 2025₹0.08 Cr
Mar 2026₹0.18 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017−₹0.05 Cr
Mar 2018−₹0.09 Cr
Mar 2019−₹0.30 Cr
Mar 2020−₹0.43 Cr
Mar 2021−₹0.06 Cr
Mar 2022−₹0.22 Cr
Mar 2023−₹0.07 Cr
Mar 2024−₹0.09 Cr
Mar 2025₹0.01 Cr
Mar 2026₹0.08 Cr

Half-yearly Results

₹ Cr
542765 half-yearly results, ₹ crore
Particulars Mar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
0.02
0
0.06
0
0.15
0
0
0
0
0
0.08
0.1
0.09
Expenses
0.04
0.06
0.02
0.23
0.14
0.03
0.03
0.03
0.03
0.03
0.02
0.03
0.04
Operating Profit
−0.02
−0.06
0.04
−0.23
0.01
−0.03
−0.03
−0.03
−0.03
−0.03
0.06
0.07
0.05
OPM %
−100%
—
66.67%
—
6.67%
—
—
—
—
—
75%
70%
55.56%
Other Income
0
0
0
0
0.01
0.05
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0.02
0.02
0.02
0.02
0.02
0
0
0
0.04
0.02
0.02
0.02
0.02
PBT
−0.04
−0.08
0.02
−0.25
0
0.02
−0.03
−0.03
−0.07
−0.05
0.04
0.05
0.03
Tax %
0%
0%
50%
0%
—
0%
0%
0%
0%
0%
0%
0%
−33.33%
Net Profit
−0.05
−0.08
0.01
−0.25
0
0.02
−0.03
−0.03
−0.06
−0.05
0.05
0.05
0.04
EPS (₹)
−1.29
−2.07
0.26
−6.46
0
0.52
−0.78
−0.78
−1.55
−1.29
1.29
1.29
1.03

Profit & Loss

₹ Cr
542765 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
0
0
0
0
0.13
0
0.03
0.15
0.38
0
0.08
0.18
Expenses
0
0.07
0.05
0.09
0.16
0.34
0.08
0.36
0.41
0.06
0.04
0.06
Operating Profit
0
−0.07
−0.05
−0.09
−0.03
−0.34
−0.05
−0.21
−0.03
−0.06
0.04
0.12
OPM %
—
—
—
—
−23.08%
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
−166.67%
−140%
−7.89%
—
50%
66.67%
Other Income
0
0
0
0
−0.23
0.02
0.03
0.03
0
0
0
0
Interest
0
0
0
0
0
0.07
0
0
0
0
0
0
Depreciation
0
0
0
0
0.02
0.04
0.04
0.04
0.04
0.04
0.04
0.04
PBT
0
−0.07
−0.05
−0.09
−0.28
−0.43
−0.06
−0.22
−0.07
−0.1
0
0.08
Tax %
—
0%
0%
0%
3.57%
2.33%
16.67%
0%
0%
0%
—
0%
Net Profit
0
−0.07
−0.05
−0.09
−0.3
−0.43
−0.06
−0.22
−0.07
−0.09
0.01
0.08
EPS (₹)
0
−2.33
−1.67
−3
−10
−11.12
−1.55
−5.69
−1.81
−2.33
0.26
2.07
Div. Payout %
—
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%

Balance Sheet

₹ Cr
542765 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.01
0.04
0.04
0.04
0.04
0.39
0.39
0.39
0.39
0.39
0.39
0.39
Reserves
0.13
0.1
0.12
0.03
−0.04
0.5
0.43
0.21
0.15
0.06
0.06
0.15
Borrowings
0.02
0.04
0.07
0.36
0.43
0.26
0.29
0.29
0.28
0.05
0.1
0.06
Other Liabilities
−0.01
0.01
0
0.04
0.09
0.15
0.27
0.21
0.22
0.16
0.15
0.18
Total Liabilities
0.15
0.19
0.23
0.47
0.52
1.3
1.38
1.1
1.04
0.66
0.7
0.78
Fixed Assets
0.13
0.13
0.18
0.18
0.35
0.31
0.27
0.24
0.2
0.16
0.13
0.09
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
0.02
0.06
0.05
0.29
0.17
0.99
1.11
0.86
0.84
0.5
0.57
0.69
Total Assets
0.15
0.19
0.23
0.47
0.52
1.3
1.38
1.1
1.04
0.66
0.7
0.78

Cash Flow

₹ Cr
542765 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
−0.12
−0.05
−0.24
0.07
−1.14
0.01
−0.87
−0.01
0.39
−0.45
0.05
Investing
0
0
−0.05
0
−0.19
0
0
0
0
0
0
0
Financing
0
0.12
0.1
0.29
0.08
1.14
0.03
−0.29
0
0
0.05
−0.04
Net Cash Flow
0
0
0
0.05
−0.05
0
0.04
−1.16
−0.01
0.39
−0.4
0.01
Free Cash Flow
0
−0.12
−0.1
−0.24
−0.12
−1.14
0.01
−0.87
−0.01
0.39
−0.45
0.05
CFO/EBITDA
—
171
100
267
−233
335
−20
414
33
−650
−1,125
42

Ratios

542765 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
—
—
—
84.23
—
0
0
0
—
456
203
Inventory Days
—
—
—
—
329
—
—
13.04
19.21
—
—
0
Days Payable
—
—
—
—
183
—
—
130
115
—
—
—
Cash Conversion Cycle
—
—
—
—
230
—
0
−117
−96.05
—
456
203
Working Capital Days
—
—
—
—
−281
—
−2,677
−925
−384
—
2,008
1,034
ROCE %
0%
−41.18%
−24.39%
−27.27%
−11.63%
−45.57%
−5.31%
−22%
−8.19%
−15.15%
0%
13.91%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Transpact Enterprises insights

53 extracted metrics across FY15–FY26.

Shareholding Pattern

As of Sep 2026

  • Public 53.19%
  • Others 30.65%
  • Promoters 16.16%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Transpact Enterprises

What does Transpact Enterprises Ltd do?
Incorporated in 2013, Transpact Enterprises Ltd deals in investment portfolio, Investment advisory, Corporate funding, Market consulting, for various clients
Where is Transpact Enterprises Ltd (TRANSPACT) listed?
Transpact Enterprises Ltd trades under code 542765 on the BSE.
Which sector does Transpact Enterprises Ltd belong to?
Transpact Enterprises Ltd is classified under the Healthcare sector, in the Medical Equipment industry.
What is the 52-week high and low of Transpact Enterprises Ltd?
Over the last 52 weeks Transpact Enterprises Ltd has traded between ₹81.47 and ₹234.9 as of 30 Oct 2026.
What is the Return on Equity (ROE) of Transpact Enterprises Ltd?
Transpact Enterprises Ltd reported a return on equity of 16.20%. Its debt-to-equity ratio is 0.11.

Company Information

Incorporated in 2013, Transpact Enterprises Ltd deals in investment portfolio, Investment advisory, Corporate funding, Market consulting, for various clients

Website transpact.in
Listed 5 Sep 2019
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/542765.md for Transpact Enterprises Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Healthcare Equipment stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month